233 institutions reported holding $658.1M of Allogene Therapeutics I (ALLO) in SEC 13F filings for 2026-06-30. Largest institutional holders: BlackRock, Inc. ($62.7M), Pfizer Inc ($46.9M), Frazier Life Sciences Management, L.P. ($46.7M), STATE STREET CORP ($39.6M), TPG GP A, LLC ($38.9M). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $62.7M | 30.1M | Added |
| 2 | Pfizer Inc | $46.9M | 22.0M | Hold |
| 3 | Frazier Life Sciences Management, L.P. | $46.7M | 22.4M | Added |
| 4 | STATE STREET CORP | $39.6M | 19.0M | Added |
| 5 | TPG GP A, LLC | $38.9M | 18.7M | Hold |
| 6 | VANGUARD GROUP INC | $38.3M | 18.4M | Added |
| 7 | Sio Capital Management, LLC | $27.7M | 13.3M | New |
| 8 | PRIMECAP MANAGEMENT CO/CA/ | $27.3M | 13.1M | Added |
| 9 | FMR LLC | $25.0M | 12.0M | Added |
| 10 | CITADEL ADVISORS LLC | $21.3M | 10.2M | Added |
| 11 | TWO SIGMA INVESTMENTS, LP | $16.2M | 7.8M | Added |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $14.7M | 7.0M | Added |
| 13 | GOLDMAN SACHS GROUP INC | $12.8M | 6.1M | Added |
| 14 | GordonMD Global Investments LP | $11.0M | 5.3M | Added |
| 15 | MARSHALL WACE, LLP | $10.6M | 5.1M | Added |
| 16 | Patient Square Capital LP | $10.5M | 5.0M | Added |
| 17 | Aberdeen Group plc | $10.4M | 5.0M | Added |
| 18 | MILLENNIUM MANAGEMENT LLC | $10.1M | 4.8M | Added |
| 19 | D. E. Shaw & Co., Inc. | $9.8M | 4.7M | Added |
| 20 | PRICE T ROWE ASSOCIATES INC /MD/ | $9.7M | 4.6M | Trimmed |
| 21 | MORGAN STANLEY | $9.4M | 4.5M | Added |
| 22 | Woodline Partners LP | $9.4M | 4.5M | Added |
| 23 | Candriam S.C.A. | $9.0M | 4.3M | Added |
| 24 | RENAISSANCE TECHNOLOGIES LLC | $8.0M | 3.8M | Added |
| 25 | HRT FINANCIAL LP | $7.5M | 3.6M | Added |
Source: SEC Form 13F filings · as of 2026-06-30